Clinical Trials Logo

Clinical Trial Summary

Antibiotics disturb the balance of gut microbiota causing dysbiosis. The purpose of this double-blind placebo controlled intervention study is to investigate whether a new prebiotic product could prevent the side effects of antibiotics.


Clinical Trial Description

Thirty children (2-6 years of age), who require antibiotic treatment assessed by a doctor, will be enrolled in the study. The children will be randomized to receive either the prebiotic product or placebo during the course of antibiotic treatment.

The children will give a faecal sample in the beginning and at the end of the study. The samples will be used for the analysis of microbiota and differences in the microbiota between the groups. ;


Study Design


Related Conditions & MeSH terms

  • Changes in the Gut Microbiota During an Antibiotic Treatment

NCT number NCT03523936
Study type Interventional
Source Turku University Hospital
Contact Seppo salminen, PhD
Phone +35823336880
Email sepsal@utu.fi
Status Not yet recruiting
Phase N/A
Start date June 1, 2018
Completion date December 31, 2019